Cystatin C as a biomarker of chronic kidney disease: latest developments
Introduction Chronic kidney disease (CKD) is common, occurring in over 10% of individuals globally, and is increasing in prevalence. The limitations of traditional biomarkers of renal dysfunction, such as serum creatinine, have been well demonstrated in the literature. Therefore, augmenting clinical...
-д хадгалсан:
| Үндсэн зохиолчид: | , , |
|---|---|
| Формат: | Revisão |
| Хэл сонгох: | англи |
| Хэвлэсэн: |
2020
|
| Онлайн хандалт: | https://doi.org/10.1080/14737159.2020.1768849 |
| Шошгууд: |
Шошго нэмэх
Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!
|
Хамгийн түрүүнд сэтгэгдэл үлдээх!